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Lipid loop instigates arthritis
Arthritic joints are chock-full of activated immune cells. These cells produce 
chemotactic proteins that lure other cells into the joint, setting up a vicious 
cycle of inflammation. But what instigates this cycle in the first place? A 
study by Kim et al. (page 829) puts much of the blame on neutrophils.
Neutrophils—granular cells that are among the immune system’s earliest 
responders during infection and injury—are required for the development 
of joint inflammation during autoantibody-induced arthritis in mice. But 
the signals that trigger this joint invasion had not been identified.
Kim and colleagues now identify a chemotactic lipid called leukotriene 
B4 (LTB4) as the instigating signal. In the absence of the receptor for LTB4 
(called BLT1), neutrophils failed to invade the joints, and mice did not 
develop arthritis. This effect was reversed when wild-type neutrophils were 
transferred into the deficient mice. Consistent 
with these data, a study by Chen et al. (page 
837) shows that LTB4 is essential for disease 
  induction in the same model.
Once in the joint, the neutrophils triggered 
the production of chemokines that attracted 
other cells—including more neutrophils—to 
the area. BLT1 expression was mandatory only 
for the initial vanguard of neutrophils that infil-
trated the joint; it was dispensable for those that 
followed—presumably because other neutro-
phil-attracting chemokines were produced.
According to Chen et al., neutrophils were 
also the primary producers of LTB4. But what 
entices the first neutrophils to enter the joint 
and, once there, what signals cause them to 
produce LTB4 are still unknown. 
The perils of locomotion
The protein that keeps the Legionnaires’ 
disease bacterium in motion also causes its 
demise, according to a study on page 1093. 
Molofsky and colleagues show that bacterial 
flagellin, which leaks out of phagosomal 
pores in infected mouse cells, triggers bac-
terial degradation and cell death.
Like many motile bacteria, Legionella 
pneumophila uses whip-like flagella in its natural 
aquatic environment. Genes that control the 
assembly of flagella are also required for the 
bug to replicate in human macrophages, a 
process that occurs when humans inhale aerosols 
from contaminated water.
In macrophages, L. pneumophila avoids 
degradation by blocking the fusion of bacteria-
containing phagosomes with degradative lyso-
somes—a feat that requires its pore-forming 
type IV secretion system.
Molofsky and colleagues now show that 
the cytosolic pathogen recognition receptor 
Naip5—which mice require to fight off L. 
pneumophila—responds to bacterial flagellin. 
The authors think that small amounts of flagellin 
inadvertently leak out of the type IV secretion 
pores in the phagosomes. This tips off Naip5-
expressing macrophages, which then trigger 
bacterial degradation and caspase-1–dependent 
cell death.
Macrophages also detected cytosolic flagellin 
from other bacteria, such as Salmonella typhimurium. 
To avoid discovery by mammalian cells, S. 
typhimurium turns off the expression of flagellin, 
which is also sensed by Toll-like receptor 5. But 
L. pneumophila, has had no evolutionary incen-
tive to mask its motor, as it does not normally 
spread between mammals. 
Two-ply brain barrier
The brain is protected by two basement membranes (BMs), protective 
layers of extracellular martix proteins that prevent cells from leaking out 
of the circulation and into tissues. According to Agrawal and colleagues 
(page 1007), the second of these barriers prevents blood cells that trigger 
the multiple sclerosis (MS)-like mouse disease experimental autoimmune 
encephalomyelitis (EAE), from invading the brain.
For EAE-causing T cells to escape the circulation and trigger disease, they 
must traverse both endothelial and parenchymal BMs. One requirement for 
getting across the first barrier is the expression of integrin α4β1, which allows 
T cells to bind the vessel endothelium. Once over this hurdle, the cells 
accumulate in the perivascular space between the two BMs. How the cells 
eventually cross the parenchymal BM—the disease-causing step—was unknown.
To get across the second barrier, Agrawal and colleagues now show, 
macrophages in the perivascular space must produce two gelatinases: 
MMP-2 and MMP-9. These enzymes selectively cleaved β-dystroglycan—a protein 
that helps anchor brain cells to proteins in the parenchymal BM. 
β-dystroglycan cleavage created breaks in the BM, allowing blood cells to 
pass through. In mice lacking both MMP-2 and MMP-9, cells were kept out 
of the brain, and the mice were protected.
Whether MMP-2 and MMP-9 initiate brain inflammation in humans 
with MS remains to be determined. If so, combined inhibition of these 
proteases might provide a way to protect against disease. 
Mice lacking the LTB4 receptor 
BLT1 are protected against 
autoantibody-induced arthritis.
Legionella pneumophila flagellin (green) is sensed by 
the cytosolic sensor Naip5 in mouse macrophages.